Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
Am J Physiol Cell Physiol. 2021 May 1;320(5):C761-C770. doi: 10.1152/ajpcell.00326.2020. Epub 2021 Feb 17.
Monocytes are a heterogeneous cell population of innate immune cells with distinct cell surface markers that help them in carrying out different functions. In humans, there are three well-characterized subsets, namely, classical (CD14CD16), intermediate (CD14CD16), and nonclassical (CD14CD16) monocytes. There is an emerging focus on the not yet well explored nonclassical monocytes that maintain vascular integrity by slowly patrolling on the endothelium, reacting to inflammatory signals, and clearing cell debris. In this manner, they are not only crucial for vascular homeostasis but also play a vital role in wound healing and resolution of inflammation by linking innate to adaptive immune response. Although they have been shown to be protective, yet they are also associated with inflammatory disease progression. This short review will give an insight about the emerging role of nonclassical monocytes in vascular homeostasis, inflammation, and protection in the context of cardiovascular disease.
单核细胞是先天免疫细胞的异质性细胞群,具有不同的细胞表面标志物,有助于它们执行不同的功能。在人类中,有三种特征明显的亚群,即经典(CD14CD16)、中间(CD14CD16)和非经典(CD14CD16)单核细胞。人们越来越关注尚未深入研究的非经典单核细胞,它们通过在血管内皮上缓慢巡逻、对炎症信号做出反应和清除细胞碎片来维持血管完整性。通过这种方式,它们不仅对血管稳态至关重要,而且通过将先天免疫与适应性免疫反应联系起来,在伤口愈合和炎症消退中也起着至关重要的作用。尽管已经表明它们具有保护作用,但它们也与炎症性疾病的进展有关。这篇简短的综述将介绍非经典单核细胞在心血管疾病背景下血管稳态、炎症和保护中的新作用。